Lisa Anson has been appointed chief executive of Redx Pharma Plc, effective 1 June, to help re-launch the company after its period in administration in 2017 in connection with a loan repayment dispute with the Liverpool, UK city council.
Ms Anson comes to the job from AstraZeneca UK where she has been president since 2012. She is also president of the Association of the British Pharmaceutical Industry. Ms Anson holds a MBA from INSEAD in France and an honours degree in natural sciences from Cambridge University.
Redx Pharma announced the appointment on 24 April 2018.
Copyright 2018 Evernow Publishing Ltd.